Clinical and biological significance of de novo CD5(+) diffuse large B-cell lymphoma in Western countries

CD5 is a pan-T-cell surface marker and is rarely expressed in diffuse large B-cell lymphoma (DLBCL). Large-scale studies of de novo CD5(+) DLBCL are lacking in Western countries. In this study by the DLBCL Rituximab-CHOP Consortium, CD5 was expressed in 5.5% of 879 DLBCL patients from Western countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu-Monette, Zijun Y., Tu, Meifeng, Jabbar, Kausar J., Cao, Xin, Tzankov, Alexandar, Visco, Carlo, Cai, Qingqing, Montes-Moreno, Santiago, An, Yuji, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Farnen, John P., Winter, Jane N., Piris, Miguel A., Miranda, Roberto N., Medeiros, L. Jeffrey, Young, Ken H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467390/
https://www.ncbi.nlm.nih.gov/pubmed/25760242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467390/
https://www.ncbi.nlm.nih.gov/pubmed/25760242

Ejemplares similares